Core Laboratories Analyst Price Targets - Benzinga

Core Laboratories Inc

CLBNYSE

Trade with Public

Trade with Public

$10.40

-0.09-0.86%

마지막 업데이트: Oct 29, 7:51 AM

개요 뉴스 실적 전망목표가재무 심리 지분 현황 배당금 비교 옵션 주식 보고서

© 2026 Benzinga | All Rights Reserved

Core Laboratories Analyst Price Targets - Benzinga

Core Laboratories Analyst Price Targets

Wall Street analyst price targets and consensus rating for Core Laboratories (CLB).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

3Hold

1Sell

Consensus RatingNeutral# Analysts4Avg. Consensus PT$14Upside to Avg. PT+37.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 16, 2025	Stifel	Stephen Gengaro	PT Cut	Hold	$13→$12
May 13, 2025	Citigroup	Scott Gruber	PT Cut	Neutral	$16→$13
Apr 15, 2025	Stifel	Stephen Gengaro	PT Cut	Hold	$19→$15
Mar 12, 2025	Citigroup	Scott Gruber	Upgrade	Sell→Neutral	$15→$16
Feb 20, 2025	Citigroup	Scott Gruber	PT Raise	Sell	$14→$15
Oct 31, 2024	Citigroup	Scott Gruber	PT Cut	Sell	$15→$14
Jul 26, 2024	Stifel	Stephen Gengaro	PT Raise	Hold	$18→$22
Jul 15, 2024	B of A Securities	Chase Mulvehill	PT Cut	Underperform	$16→$15
Jul 15, 2024	Piper Sandler	Luke Lemoine	PT Cut	Neutral	$18→$17
Apr 26, 2024	Stifel	Stephen Gengaro	PT Raise	Hold	$17→$18
Apr 15, 2024	B of A Securities	Chase Mulvehill	PT Cut	Underperform	$17→$16
Feb 5, 2024	Stifel	Stephen Gengaro	PT Cut	Hold	$21→$17
Jan 29, 2024	Stifel	Stephen Gengaro	PT Cut	Hold	$23→$21

Analyst Ratings News

PRO
Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $12

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $13 to $12.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Core Laboratories, Lowers Price Target to $13

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Neutral and lowers the price target from $16 to $13.

Benzinga Newsdesk

PRO
Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $15

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $19 to $15.

Benzinga Newsdesk

PRO
Citigroup Upgrades Core Laboratories to Neutral, Raises Price Target to $16

Citigroup analyst Scott Gruber upgrades Core Laboratories (NYSE:CLB) from Sell to Neutral and raises the price target from $15 to $16.

Benzinga Newsdesk

PRO
Citigroup Maintains Sell on Core Laboratories, Raises Price Target to $15

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and raises the price target from $14 to $15.

Benzinga Newsdesk

PRO
Citigroup Maintains Sell on Core Laboratories, Lowers Price Target to $14

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and lowers the price target from $15 to $14.

Benzinga Newsdesk